Wu; Yingyun

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wu; Yingyun.The latest application filed is for "modified rsv f proteins and methods of their use".

Company Profile

4.13.18

Wu; Yingyun - Clarksburg MD
Wu; Yingyun - Gaithersburg MD
Wu; Yingyun - Rockville MD US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modified RSV F proteins and methods of their use Grant 11,446,374 - Pushko , et al. September 20, 2	2022-09-20
Modified RSV F proteins and methods of their use Grant 11,052,146 - Pushko , et al. July 6, 2	2021-07-06
Modified Rsv F Proteins And Methods Of Their Use App 20200030436 - PUSHKO; Peter M. ; et al.	2020-01-30
Highly efficient influenza matrix (M1) proteins Grant 10,544,399 - Smith , et al. Ja	2020-01-28
Modified Rsv F Proteins And Methods Of Their Use App 20190134187 - PUSHKO; Peter M. ; et al.	2019-05-09
Highly Efficient Influenza Matrix (m1) Proteins App 20190062713 - SMITH; Gale ; et al.	2019-02-28
Modified RSV F proteins and methods of their use Grant 10,022,437 - Pushko , et al. July 17, 2	2018-07-17
Highly efficient influenza matrix (M1) proteins Grant 9,951,317 - Smith , et al. April 24, 2	2018-04-24
Recombinant Nanoparticle Rsv F Vaccine For Respiratory Syncytial Virus App 20170319682 - SMITH; Gale ; et al.	2017-11-09
Highly Efficient Influenza Matrix (m1) Proteins App 20170253861 - SMITH; Gale ; et al.	2017-09-07
Modified RSV F proteins and methods of their use Grant 9,731,000 - Pushko , et al. August 15, 2	2017-08-15
Modified RSV F proteins and methods of their use Grant 9,717,786 - Pushko , et al. August 1, 2	2017-08-01
Modified RSV F proteins and methods of their use Grant 9,675,685 - Pushko , et al. June 13, 2	2017-06-13
Highly efficient influenza matrix (M1) proteins Grant 9,464,276 - Smith , et al. October 11, 2	2016-10-11
Modified Rsv F Proteins And Methods Of Their Use App 20150359872 - PUSHKO; Peter ; et al.	2015-12-17
Recombinant Nanoparticle Rsv F Vaccine For Respiratory Syncytial Virus App 20150335730 - SMITH; Gale ; et al.	2015-11-26
Recombinant Nanoparticle Rsv F Vaccine For Respiratory Syncytial Virus App 20150306207 - SMITH; Gale ; et al.	2015-10-29
Highly Efficient Influenza Matrix (m1) Proteins App 20150307849 - SMITH; Gale ; et al.	2015-10-29
Modified Rsv F Proteins And Methods Of Their Use App 20150265698 - PUSHKO; Peter ; et al.	2015-09-24
Modified Rsv F Proteins And Methods Of Their Use App 20150266930 - PUSHKO; Peter ; et al.	2015-09-24
Highly efficient influenza matrix (M1) proteins Grant 8,992,939 - Smith , et al. March 31, 2	2015-03-31
Modified Rsv F Proteins And Methods Of Their Use App 20140294879 - PUSHKO; Peter ; et al.	2014-10-02
Modified RSV F proteins and methods of their use Grant 8,715,692 - Pushko , et al. May 6, 2	2014-05-06
Recombinant Nanoparticle Rsv F Vaccine For Respiratory Syncytial Virus App 20130122032 - SMITH; Gale ; et al.	2013-05-16
Highly Efficient Influenza Matrix (m1) Proteins App 20130039938 - SMITH; Gale ; et al.	2013-02-14
Modified Rsv F Proteins And Methods Of Their Use App 20100239617 - PUSHKO; Peter ; et al.	2010-09-23
Respiratory Syncytial Virus-virus Like Particle (vlps) App 20080233150 - SMITH; Gale ; et al.	2008-09-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.